By Susanna Moon
Chicago, Oct. 16 – Morgan Stanley priced $1.34 million of 7.8% airbag autocallable yield optimization notes due Oct. 19, 2015 linked to Biogen Idec Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.
Interest is payable monthly.
The notes will be called at par if Biogen Idec shares close at or above the initial share price on any quarterly observation date.
The payout at maturity will be par unless the final share price is less than the conversion price, in which case the payout will be a number of Biogen Idec shares equal to $1,000 divided by the conversion price. The conversion price is 85% of the initial share price.
Morgan Stanley & Co. LLC is the agent. UBS Financial Services Inc. is acting as dealer.
| Issuer: | Morgan Stanley
|
| Issue: | Airbag autocallable yield optimization notes
|
| Underlying stock: | Biogen Idec Inc. (Symbol: BIIB)
|
| Amount: | $1,338,000
|
| Maturity: | Oct. 19, 2015
|
| Coupon: | 7.8%, payable monthly
|
| Price: | Par
|
| Payout at maturity: | Par unless final share price is less than conversion price, in which case number of Biogen Idec shares equal to $1,000 divided by conversion price
|
| Call: | At par if Biogen Idec shares close at or above initial share price on any quarterly observation date
|
| Initial share price: | $315.14
|
| Conversion price: | $277.32, 88% of initial share price
|
| Pricing date: | Oct. 10
|
| Settlement date: | Oct. 16
|
| Agent: | Morgan Stanley & Co. LLC
|
| Dealer: | UBS Financial Services Inc.
|
| Fees: | 1.5%
|
| Cusip: | 61764C366
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
